Cross Country Healthcare, Inc. (NASDAQ:CCRN) has been assigned an average rating of “Hold” from the ten research firms that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $15.64.

A number of research analysts recently weighed in on the company. TheStreet upgraded Cross Country Healthcare from a “c+” rating to a “b” rating in a report on Wednesday, September 27th. Benchmark Co. reduced their target price on Cross Country Healthcare from $18.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, August 3rd. Zacks Investment Research cut Cross Country Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. BMO Capital Markets reduced their target price on Cross Country Healthcare from $15.00 to $14.00 and set an “outperform” rating on the stock in a report on Monday, November 6th. Finally, BidaskClub cut Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th.

In related news, Director Thomas C. Dircks acquired 10,000 shares of Cross Country Healthcare stock in a transaction on Monday, November 6th. The shares were bought at an average price of $11.77 per share, for a total transaction of $117,700.00. Following the completion of the purchase, the director now directly owns 104,571 shares in the company, valued at approximately $1,230,800.67. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider William J. Grubbs sold 49,113 shares of the business’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $12.16, for a total value of $597,214.08. Following the transaction, the insider now owns 395,188 shares in the company, valued at approximately $4,805,486.08. The disclosure for this sale can be found here. Insiders own 3.90% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of CCRN. BNP Paribas Arbitrage SA lifted its stake in shares of Cross Country Healthcare by 57.7% in the second quarter. BNP Paribas Arbitrage SA now owns 9,998 shares of the business services provider’s stock worth $129,000 after acquiring an additional 3,660 shares in the last quarter. FDx Advisors Inc. acquired a new position in shares of Cross Country Healthcare in the third quarter worth about $146,000. Strs Ohio lifted its stake in shares of Cross Country Healthcare by 69.5% in the third quarter. Strs Ohio now owns 16,100 shares of the business services provider’s stock worth $229,000 after acquiring an additional 6,600 shares in the last quarter. Stevens Capital Management LP acquired a new position in shares of Cross Country Healthcare in the third quarter worth about $249,000. Finally, Voya Investment Management LLC lifted its stake in shares of Cross Country Healthcare by 16.9% in the second quarter. Voya Investment Management LLC now owns 18,329 shares of the business services provider’s stock worth $237,000 after acquiring an additional 2,646 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Shares of Cross Country Healthcare (NASDAQ:CCRN) traded up $0.06 during trading on Thursday, reaching $12.72. The company had a trading volume of 150,043 shares, compared to its average volume of 248,594. Cross Country Healthcare has a 52-week low of $11.07 and a 52-week high of $16.38. The firm has a market capitalization of $464.04, a PE ratio of 19.88, a P/E/G ratio of 1.13 and a beta of 0.77. The company has a quick ratio of 2.14, a current ratio of 2.14 and a debt-to-equity ratio of 0.46.

Cross Country Healthcare (NASDAQ:CCRN) last issued its earnings results on Wednesday, November 1st. The business services provider reported $0.23 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.18 by $0.05. Cross Country Healthcare had a return on equity of 11.69% and a net margin of 0.19%. The firm had revenue of $228.50 million for the quarter, compared to analysts’ expectations of $228.97 million. During the same quarter last year, the firm earned $0.24 earnings per share. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. analysts predict that Cross Country Healthcare will post 0.64 EPS for the current fiscal year.

WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/11/19/cross-country-healthcare-inc-ccrn-receives-15-64-average-target-price-from-analysts.html.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.